Purchase Order HHSN272201501141P
- Not listed
- This is a $4,250 firm-fixed-price purchase order contract between the National Institute of Allergy and Infectious Diseases (NIAID) and Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services. The contract is not set aside and supports NIAID's biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases. Miltenyi Biotec has extensive experience as a prime contractor for numerous...
- This is a $8,379.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company, for the supply of biomaterials. The award is not designated as a set-aside contract. Miltenyi Biotec is a prime contractor that frequently supports federal biomedical research programs with its specialized cell separation, analysis, and processing technologies, including flow cytometers, cell sorters, and...
- This is a $3,641 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract does not have a set-aside designation. The award supports NIAID's biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases. Key deliverables include the supply of FDA-approved,...
- This $4,881 firm fixed-price purchase order was awarded to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research and cell therapy development. The award is for the delivery of lab equipment to the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). Miltenyi Biotec has extensive experience as a prime contractor for federal...
- This is a $14,781 fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. The contract is for the supply of specialized biotechnology products and services, including cell separation and analysis equipment, reagents, and consumables. Miltenyi Biotec is a global biotechnology company that frequently provides equipment and supplies to federal agencies like the NIH,...
- This is a federal contract award to Miltenyi Biotec, Inc., a biotechnology company that provides specialized scientific instruments, reagents, and services to government agencies. The award, valued at $4,563.50, is for the acquisition of antibodies from Miltenyi Biotec. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and is a firm fixed-price purchase order with no set-aside designation. Miltenyi...
- This is a fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The $4,250 contract is for the supply of specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. Miltenyi Biotec has significant experience as a prime contractor for various...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company, for the delivery of a cell dissociator and cell separator. The award, valued at $58,517.50, was made without a set-aside designation and has an ultimate completion date of September 30, 2017. Miltenyi Biotec is a well-established federal contractor,...
- This federal contract award to Miltenyi Biotec, Inc. is a $5,400 firm fixed-price purchase order from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The contract is not set aside and has an ultimate completion date of May 15, 2013. Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. The $12,810 contract provides for the delivery of specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. Key deliverables include flow cytometers, cell sorters, tissue dissociators, automated cell...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract is valued at $4,058.00 and provides for the delivery of Miltenyi Biotec's dissociation kits, buffers, and antibodies. This award is not associated with a set-aside designation. Miltenyi Biotec has extensive experience as a prime contractor for numerous federal agencies, including the NIH, VA, FDA, DoD, CDC, and USDA. The company frequently provides maintenance, repair, and technical support services for its instruments at government facilities, in addition to delivering specialized laboratory equipment and proprietary reagents, microbeads, and consumables used in cell isolation and analysis. This particular contract supports biomedical research programs at the NIAID. Additionally, Miltenyi Biotec holds a $2.3 million single-award indefinite delivery contract with the NIH Clinical Center, which provides for the supply of proprietary CliniMACS cell isolation reagents and consumables through September 2024, with options to extend to 2027. This sole-source contract ensures the availability of FDA-approved, clinical-grade reagents and supplies compatible with the NIH's existing CliniMACS instrumentation to support the center's cell processing and manufacturing capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Other Administrative Action | ($7) | 1/25/16 | |
| Not listed | Not listed | $4.1k | 8/23/15 |